LongueVue Capital Announces Dedicated Operating Partner and is Seeking Medical Contract Manufacturing Opportunities

Following successful investments across the medical device & outsourced manufacturing sectors, LongueVue Capital (“LVC”), together with its new Medical Contract Manufacturing Operating Partner, Bill Flaherty, is actively seeking new medical contract manufacturing platform investments.

Bill has over 20 years of medical contract manufacturing experience, most recently as CEO of iiMED Medical Manufacturing Solutions, which offers end-to-end nearshore outsourced manufacturing services for Class I and II consumable medical devices.

Prior to joining iiMed, Bill served as the Chief Commercial Officer for Viant Medical, where he oversaw global sales, business development, pricing, marketing, and technical solutions. In 2017, Viant, a private equity backed end-to-end global contract manufacturer of medical devices and components, acquired Vention Medical’s device business. At the time of Viant's acquisition, Bill was serving as President of Vention, a leading global manufacturer of complex medical devices and components focused on the interventional and surgical technologies markets. Prior to Vention, Bill served in various roles at Flextronics, ultimately as President of FlexMedical, where he oversaw 8,000 employees and was responsible for a $1.3 billion operating business focused on the design, manufacturing, and distribution of diagnostics devices, drug delivery devices, and sterile devices for wound care and minimally invasive surgery.

Bill brings unrivaled expertise and extensive industry contacts to support both LVC’s sourcing and execution efforts, while also providing strategic guidance to our portfolio companies post-closing as a proactive board member.


medical manufacturing opportunities criteria


ECA Overview: ECA Medical Instruments (“ECA”) is a leading designer and contract manufacturer of advanced single-use medical instrumentation. ECA leverages proprietary technology, a robust quality management system, design and development, vertically-integrated manufacturing capabilities, and validated solutions with a focus on single-use instrumentation.

LVC Value Creation: Since closing, LVC has made significant investments in product development, in-house mold-making, and off-the-shelf validations to increase speed to market of surgery-ready products. In addition to recruiting a CEO, CFO, and COO, LVC supported a 5x growth of the engineering team and a 4x increase in employees with Medical Contract Manufacturing experience. LVC has strategically expanded ECA’s operating footprint from two facilities to four facilities greatly increasing scalability.

eca infographic


LVC’s investment and operating team have significant experience within the medical contract manufacturing space including investments in or operating roles with:

LVC related investments

To learn more about LongueVue Capital, please visit our website at www.lvcpartners.com or contact Ryan Nagim, Managing Partner & Head of Healthcare, at rnagim@lvcpartners.com, Austin Rees, Principal, at arees@lvcpartners.com, or call 504.293.3600.

About LongueVue Capital

Founded in 2001, LongueVue Capital is a New Orleans-based equity investment firm focused on providing transformational growth capital to middle-market companies, drawing upon its successful 20+ year track record of partnering with entrepreneurs and management teams to drive value creation. With over $850 million of committed capital spanning four funds coupled with 150 years of combined operating and investing experience, the LVC team is an ideal partner for middle-market companies at inflection points and seeking to maximize value for all stakeholders. LVC has made successful investments in a wide variety of industries including healthcare, life sciences, transportation and logistics, food and beverage, specialty packaging, consumer, and industrial services. For more information, please visit www.lvcpartners.com, and for media inquiries, please contact lvc@lvcpartners.com or call 504.293.3600.